Sulfation of ractopamine and salbutamol by the human cytosolic sulfotransferases. 2012

Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
Department of Pharmacology, College of Pharmacy and Pharmaceutical Sciences, The University of Toledo, Toledo, OH 43614, USA.

Feed additives such as ractopamine and salbutamol are pharmacologically active compounds, acting primarily as β-adrenergic agonists. This study was designed to investigate whether the sulfation of ractopamine and salbutamol may occur under the metabolic conditions and to identify the human cytosolic sulfotransferases (SULTs) that are capable of sulfating two major feed additive compounds, ractopamine and salbutamol. A metabolic labelling study showed the generation and release of [(35)S]sulfated ractopamine and salbutamol by HepG2 human hepatoma cells labelled with [(35)S]sulfate in the presence of these two compounds. A systematic analysis using 11 purified human SULTs revealed SULT1A3 as the major SULT responsible for the sulfation of ractopamine and salbutamol. The pH dependence and kinetic parameters were analyzed. Moreover, the inhibitory effects of ractopamine and salbutamol on SULT1A3-mediated dopamine sulfation were investigated. Cytosol or S9 fractions of human lung, liver, kidney and small intestine were examined to verify the presence of ractopamine-/salbutamol-sulfating activity in vivo. Of the four human organs, the small intestine displayed the highest activity towards both compounds. Collectively, these results imply that the sulfation mediated by SULT1A3 may play an important role in the metabolism and detoxification of ractopamine and salbutamol.

UI MeSH Term Description Entries
D007553 Isotope Labeling Techniques for labeling a substance with a stable or radioactive isotope. It is not used for articles involving labeled substances unless the methods of labeling are substantively discussed. Tracers that may be labeled include chemical substances, cells, or microorganisms. Isotope Labeling, Stable,Isotope-Coded Affinity Tagging,Isotopically-Coded Affinity Tagging,Affinity Tagging, Isotope-Coded,Affinity Tagging, Isotopically-Coded,Isotope Coded Affinity Tagging,Labeling, Isotope,Labeling, Stable Isotope,Stable Isotope Labeling,Tagging, Isotope-Coded Affinity,Tagging, Isotopically-Coded Affinity
D007700 Kinetics The rate dynamics in chemical or physical systems.
D009928 Organ Specificity Characteristic restricted to a particular organ of the body, such as a cell type, metabolic response or expression of a particular protein or antigen. Tissue Specificity,Organ Specificities,Specificities, Organ,Specificities, Tissue,Specificity, Organ,Specificity, Tissue,Tissue Specificities
D010627 Phenethylamines A group of compounds that are derivatives of beta- aminoethylbenzene which is structurally and pharmacologically related to amphetamine. (From Merck Index, 11th ed) Phenylethylamines
D003600 Cytosol Intracellular fluid from the cytoplasm after removal of ORGANELLES and other insoluble cytoplasmic components. Cytosols
D004298 Dopamine One of the catecholamine NEUROTRANSMITTERS in the brain. It is derived from TYROSINE and is the precursor to NOREPINEPHRINE and EPINEPHRINE. Dopamine is a major transmitter in the extrapyramidal system of the brain, and important in regulating movement. A family of receptors (RECEPTORS, DOPAMINE) mediate its action. Hydroxytyramine,3,4-Dihydroxyphenethylamine,4-(2-Aminoethyl)-1,2-benzenediol,Dopamine Hydrochloride,Intropin,3,4 Dihydroxyphenethylamine,Hydrochloride, Dopamine
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D000420 Albuterol A short-acting beta-2 adrenergic agonist that is primarily used as a bronchodilator agent to treat ASTHMA. Albuterol is prepared as a racemic mixture of R(-) and S(+) stereoisomers. The stereospecific preparation of R(-) isomer of albuterol is referred to as levalbuterol. Salbutamol,2-t-Butylamino-1-(4-hydroxy-3-hydroxy-3-hydroxymethyl)phenylethanol,Albuterol Sulfate,Proventil,Sultanol,Ventolin
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities

Related Publications

Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
January 2014, Drug metabolism letters,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
March 1994, The Journal of steroid biochemistry and molecular biology,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
January 2002, Drug metabolism and pharmacokinetics,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
February 1998, Chemico-biological interactions,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
January 1997, FASEB journal : official publication of the Federation of American Societies for Experimental Biology,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
October 2017, Pharmacological reports : PR,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
March 2006, Drug metabolism and disposition: the biological fate of chemicals,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
June 2012, Drug metabolism letters,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
January 2012, Biological & pharmaceutical bulletin,
Kyounga Ko, and Katsuhisa Kurogi, and Garrett Davidson, and Ming-Yih Liu, and Yoichi Sakakibara, and Masahito Suiko, and Ming-Cheh Liu
January 2000, Biochemical and biophysical research communications,
Copied contents to your clipboard!